XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current Assets    
Cash $ 35,703,215 $ 33,146,725
Accounts receivable, net 5,667,942 5,277,250
Product deposit 116,134 485,850
Inventory, net 2,060,719 2,759,932
Other current assets 1,521,420 934,510
Total Current Assets 45,069,430 42,604,267
Non-current Assets    
Equipment, net 1,123,582 476,303
Right of use assets 2,534,731 594,897
Capitalized software, net 12,573,579 11,795,979
Intangible assets, net 2,519,167 3,009,263
Total Non-current Assets 18,751,059 15,876,442
Total Assets 63,820,489 58,480,709
Current Liabilities    
Accounts payable 15,051,729 11,084,855
Accrued expenses 14,751,501 13,937,494
Notes payable, net 13,020 327,597
Current operating lease liabilities 337,276 603,180
Current portion of long-term debt 6,333,333
Deferred revenue 15,161,659 8,828,598
Total Current Liabilities 51,648,518 34,781,724
Long-term Liabilities    
Long-term debt, net 11,795,281 17,927,727
Noncurrent operating lease liabilities 2,336,194 73,849
Contingent consideration 100,000 131,250
Total Liabilities 65,879,993 52,914,550
Commitments and contingencies (Note 10)
Mezzanine Equity    
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding, liquidation value, $0 per share as of June 30, 2024 and December 31, 2023
Stockholders’ (Deficit) Equity    
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $25.55 per share as of June 30, 2024 and December 31, 2023 140 140
Common Stock, $0.01 par value; 100,000,000 shares authorized, 41,759,572 and 38,358,641 shares issued, 41,656,532 and 38,255,601 outstanding as of June 30, 2024 and December 31, 2023, respectively 417,596 383,586
Additional paid-in capital 225,001,992 217,550,583
Accumulated deficit (229,462,356) (214,265,236)
Treasury stock, 103,040, at cost, as of June 30, 2024 and December 31, 2023 (163,701) (163,701)
Total LifeMD, Inc. Stockholders’ (Deficit) Equity (4,206,329) 3,505,372
Non-controlling interest 2,146,825 2,060,787
Total Stockholders’ (Deficit) Equity (2,059,504) 5,566,159
Total Liabilities, Mezzanine Equity and Stockholders’ (Deficit) Equity $ 63,820,489 $ 58,480,709